Diagnosing Type 1 diabetes in adults: Guidance from the UK T1D Immunotherapy consortium
dc.contributor.author | Tatovic, D | |
dc.contributor.author | Jones, AG | |
dc.contributor.author | Evans, C | |
dc.contributor.author | Long, AE | |
dc.contributor.author | Gillespie, K | |
dc.contributor.author | Besser, REJ | |
dc.contributor.author | Leslie, RD | |
dc.contributor.author | Dayan, CM | |
dc.contributor.author | Type 1 diabetes UK Immunotherapy Consortium | |
dc.date.accessioned | 2023-02-24T13:12:11Z | |
dc.date.issued | 2022-05-06 | |
dc.date.updated | 2023-02-24T12:21:18Z | |
dc.description.sponsorship | National Institute for Health Research (NIHR) | en_GB |
dc.identifier.citation | Vol. 39, No. 7, article e14862 | en_GB |
dc.identifier.doi | https://doi.org/10.1111/dme.14862 | |
dc.identifier.uri | http://hdl.handle.net/10871/132538 | |
dc.identifier | ORCID: 0000-0002-0883-7599 (Jones, Angus G) | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/35488476 | en_GB |
dc.rights | © 2022 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_GB |
dc.subject | Adult | en_GB |
dc.subject | Diabetes Mellitus, Type 1 | en_GB |
dc.subject | Diabetes Mellitus, Type 2 | en_GB |
dc.subject | Genetic Predisposition to Disease | en_GB |
dc.subject | Humans | en_GB |
dc.subject | Immunotherapy | en_GB |
dc.subject | United Kingdom | en_GB |
dc.title | Diagnosing Type 1 diabetes in adults: Guidance from the UK T1D Immunotherapy consortium | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2023-02-24T13:12:11Z | |
dc.identifier.issn | 0742-3071 | |
exeter.article-number | ARTN e14862 | |
exeter.place-of-publication | England | |
dc.description | This is the final version. Available from Wiley via the DOI in this record. | en_GB |
dc.identifier.eissn | 1464-5491 | |
dc.identifier.journal | Diabetic Medicine | en_GB |
dc.relation.ispartof | Diabet Med, 39(7) | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_GB |
dcterms.dateAccepted | 2022-04-25 | |
dc.rights.license | CC BY-NC-ND | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2022-05-06 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2023-02-24T13:07:04Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2023-02-24T13:12:16Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2022-05-06 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2022 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.